Morgan Lewis Guides Chiesi In $255M Cornerstone Takeover

Law360, New York (September 16, 2013, 1:28 PM EDT) -- Italian pharmaceutical company Chiesi Farmaceutici SpA. said Monday it will buy up remaining shares in Cornerstone Therapeutics Inc. for $255 million in a deal aimed at boosting its presence in the United States and its stake in the respiratory treatment market.

Chiesi, which currently owns 58 percent of Cornerstone, plans to shell out $9.50 in cash per Cornerstone share, the companies said Monday. The deal is valued at approximately $255 million for Cornerstone’s outstanding shares — 26.8 million as of Aug. 1, according to regulatory filings....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.